TIDMBYOT

RNS Number : 3557V

Byotrol PLC

13 December 2021

Byotrol plc ("Byotrol" or the "Company")

Directorate Change

Byotrol plc (AIM: BYOT), the infection prevention technology company, is pleased to announce the appointment of Chris Sedwell as CFO of the Company. Chris joins the Board of Directors with immediate effect.

Nic Hellyer, part-time CFO since May 2019 has now formally left the Company, but will continue to be available to assist in an orderly handover process.

Chris is ACA trained and an ICAEW fellow. He was most recently Portfolio Finance Director of FD & CFO Centre, working with various SMEs to provide finance consultancy. For the preceding six years he was Finance Director of ConvaTec Limited, a FTSE250 listed medical products and technologies business. Prior to this, he was Head of Finance & Administration at Iceland International, a part of the UK supermarket chain Iceland Foods Group.

At the date of this announcement, Mr Sedwell does not have any beneficial interest in the ordinary shares of the Company.

Commenting on the appointment, John Langlands, Chairman of Byotrol plc, said:

"We are very pleased to welcome Chris Sedwell to the Board of Byotrol. He has a wealth of highly relevant industrial and healthcare experience, from listed company to SME. We are convinced that he will be a very important asset to the Company as we continue to grow and develop.

We thank Nic Hellyer for his service to the Company and wish him every success for the future."

Enquiries:

 
 Byotrol Plc 
 John Langlands - Chairman 
  David Traynor - Chief Executive                          +44 (0)1925 742 000 
 
 finnCap (Nominated Adviser and Broker)                    +44 (0)20 7220 0500 
 Geoff Nash/Kate Bannatyne - Corporate 
  Finance 
 Richard Chambers - ECM 
 
 Flagstaff Strategic and Investor Communications           +44 (0)20 7129 1474 
 Tim Thompson/Andrea Seymour/Fergus Mellon          byotrol@flagstaffcomms.com 
 

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to byotrol.co.uk

Christopher John Sedwell, aged 45, is, or has been within the last five years, a director or partner in the following companies and partnerships:

 
 Current directorships and partnerships   Previous directorships and partnerships 
                                              held within the last five years 
---------------------------------------  ---------------------------------------- 
 S edwell Consulting Limited              C onvaTec Limited 
                                           Unomedical Holdings Limited 
                                           C onvaTec Accessories Limited 
                                           Unomedical Limited 
                                           Amcare Limited 
                                           Alpha-Med (Medical & Surgical) 
                                           Limited 
                                           SureCalm Healthcare Limited 
                                           SureCalm Pharmacy Limited 
                                           Surecalm Healthcare Holdings 
                                           Limited 
                                           B.C.A Direct Limited 
                                           Resus Positive Limited 
                                           Akers & Dickinson Limited 
                                           Novacare UK Limited 
                                           Unomedical Developments Limited 
                                           Unoplast (UK) Limited 
                                           Steriseal Limited 
                                           Pharma-Plast Limited 
                                           Farnhurst Medical Limited 
                                           ConvaTec Speciality Fibres Limited 
                                           Nottingham Medical Equipment 
                                           Limited 
                                           Needle Industries (Sheffield) 
                                           Limited 
                                           Lance Blades Limited 
                                           M.S.B Limited 
                                           Rotax Razor Company Limited 
                                           Arthur Wood Limited 
                                           Allied Medical Services (UK) 
                                           Limited 
                                           Bradgate-Unitech Limited 
                                           Shrimpton & Fletcher Limited 
---------------------------------------  ---------------------------------------- 
 

There are no further disclosures regarding Chris Sedwell pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAEAXAAFAAFFFA

(END) Dow Jones Newswires

December 13, 2021 02:00 ET (07:00 GMT)

Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Byotrol
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Byotrol